In TRANSCEND-T2D-2, retatrutide lowered A1C 2.2 points vs 1.8 with semaglutide 2 mg and more than doubled weight loss at 80 weeks.
|Podcasts|August 26, 2017
Podcast: This Week in Managed Care - When to Start Mammography, and Other Health News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Advertisement
Every week, The American Journal of Managed Care® recaps the
This week, the top stories in managed care include a study on which mammogram recommendations to follow; findings that continuous glucose monitoring benefits patients with type 2 diabetes; and a new position statement on treating patients with diabetes and hypertension.
Listen below or through one of these podcast services:
iTunes:
TuneIn:
Stitcher:
Advertisement
Related to this article
Shields Health Solutions leaders say GLP-1 discontinuation is a support problem, not a medication problem, and pharmacist-led care can help close it.
Advertisement
Advertisement
Trending on AJMC
1
HHS Draft Policy Eases Enforcement on 6 Compounded Peptides
2
BPC-157 'Wolverine Peptide' Use Rose 33-Fold Despite Scant Evidence
3
5 Things to Know About HHS's Interim Peptide Compounding Policy
4
Approval Is Just One Piece of the Specialty Drug Pie
5